These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Prolonged Hypophosphatemia and Intensive Care After Curative Surgery of Tumor Induced Osteomalacia: A Case Report. Ryhänen EM; Schalin-Jäntti C; Matikainen N Front Endocrinol (Lausanne); 2021; 12():686135. PubMed ID: 34149623 [TBL] [Abstract][Full Text] [Related]
23. Global guidance for the recognition, diagnosis, and management of tumor-induced osteomalacia. Jan de Beur SM; Minisola S; Xia WB; Abrahamsen B; Body JJ; Brandi ML; Clifton-Bligh R; Collins M; Florenzano P; Houillier P; Imanishi Y; Imel EA; Khan AA; Zillikens MC; Fukumoto S J Intern Med; 2023 Mar; 293(3):309-328. PubMed ID: 36511653 [TBL] [Abstract][Full Text] [Related]
24. Renal Phosphate Wasting Due to Tumor-Induced (Oncogenic) Osteomalacia. Amaratunga EA; Ernst EB; Kamau J; Kotala R; Snyder R Cureus; 2021 Jun; 13(6):e15507. PubMed ID: 34268038 [TBL] [Abstract][Full Text] [Related]
25. Oncogenic osteomalacia caused by a phosphaturic mesenchymal tumor of the thoracic spine. Pirola E; Vergani F; Casiraghi P; Leone EB; Guerra P; Sganzerla EP J Neurosurg Spine; 2009 Apr; 10(4):329-33. PubMed ID: 19441990 [TBL] [Abstract][Full Text] [Related]
30. [Oncogenic osteomalacia: the role of the phosphatonins. Diagnostic usefulness of the Fibroblast Growth Factor 23 measurement in one patient]. Dupond JL; Magy N; Mahammedi M; Prie D; Gil H; Meaux-Ruault N; Kantelip B Rev Med Interne; 2005 Mar; 26(3):238-41. PubMed ID: 15777586 [TBL] [Abstract][Full Text] [Related]
31. Tumor-Induced Osteomalacia and the Importance of Plasma Fibroblast Growth Factor 23 as an Indicator: Diagnostic Delay Leads to a Suicide Attempt. Seemann L; Padala SA; Mohammed A; Belayneh N J Investig Med High Impact Case Rep; 2019; 7():2324709619895162. PubMed ID: 31850815 [TBL] [Abstract][Full Text] [Related]
32. PET/CT localisation of a scapular haemangiopericytoma with tumour-induced osteomalacia. Khadgawat R; Singh Y; Kansara S; Tandon N; Bal C; Seith A; Kotwal P Singapore Med J; 2009 Feb; 50(2):e55-7. PubMed ID: 19296011 [TBL] [Abstract][Full Text] [Related]
33. Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients. Zuo QY; Wang H; Li W; Niu XH; Huang YH; Chen J; You YH; Liu BY; Cui AM; Deng W BMC Musculoskelet Disord; 2017 Sep; 18(1):403. PubMed ID: 28934935 [TBL] [Abstract][Full Text] [Related]
34. Locally aggressive and multifocal phosphaturic mesenchymal tumors: two unusual cases of tumor-induced osteomalacia. Higley M; Beckett B; Schmahmann S; Dacey E; Foss E Skeletal Radiol; 2015 Dec; 44(12):1825-31. PubMed ID: 26341245 [TBL] [Abstract][Full Text] [Related]
35. Mesenchymal phosphaturic neoplasm in the maxillary sinus: a case report. Pedrazzoli M; Colletti G; Ferrari M; Rossetti G; Moneghini L; Autelitano L Int J Oral Maxillofac Surg; 2010 Oct; 39(10):1027-32. PubMed ID: 20483563 [TBL] [Abstract][Full Text] [Related]
36. The Right Leg that Troubled the Left Leg. B S; V A J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116017 [TBL] [Abstract][Full Text] [Related]
37. Long-term use of burosumab for the treatment of tumor-induced osteomalacia. Crotti C; Zucchi F; Alfieri C; Caporali R; Varenna M Osteoporos Int; 2023 Jan; 34(1):201-206. PubMed ID: 35925260 [TBL] [Abstract][Full Text] [Related]
38. Tumor-induced osteomalacia - a mystery illness beyond aches, pains, and depression. Ni HJ; Clifton-Bligh R; Brzozowska MM Endocr Regul; 2021 Sep; 55(3):163-168. PubMed ID: 34523297 [No Abstract] [Full Text] [Related]